Other functions
Ended Awarded Last action
- Contract number
- HHSF22301003T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $237,188
Award facts
- Contract value 100% obligated
- $237,188.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,348 | |
| Original award | $239,537 |
About this award
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation.
Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. These products and services are intended to support genomic sequencing and analysis for research and diagnostic purposes across various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), and Department of Veterans Affairs (VA).
The contract is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery, focused on providing sequencing platforms and supplies to support the Naval Medical Research Center's Biological Defense Research Directorate.
Quick answers
Who was awarded contract HHSF22301003T?
HHSF22301003T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 10, 2016.
How much is contract HHSF22301003T worth?
The government has obligated $237,188 on HHSF22301003T.
Is contract HHSF22301003T an order under another contract?
Yes. HHSF22301003T is a delivery order under HHSF223201510010I, an indefinite delivery contract.
Was contract HHSF22301003T competed?
The extent of competition for HHSF22301003T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award